According to Fresenius Medical Care's latest financial reports the company's current revenue (TTM) is $20.45 B. In 2022 the company made a revenue of $20.40 B a decrease over the years 2021 revenue that were of $20.49 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $20.45 B | 0.26% |
2022 | $20.40 B | -0.42% |
2021 | $20.49 B | -0.86% |
2020 | $20.67 B | 5.77% |
2019 | $19.54 B | 0.5% |
2018 | $19.44 B | -4.74% |
2017 | $20.41 B | 13.92% |
2016 | $17.91 B | 7.02% |
2015 | $16.74 B | 5.75% |
2014 | $15.83 B | 10.25% |
2013 | $14.36 B | 6.43% |
2012 | $13.49 B | 1.99% |
2011 | $13.22 B | 7.59% |
2010 | $12.29 B | 7.63% |
2009 | $11.42 B | 6.57% |
2008 | $10.72 B | 11.87% |
2007 | $9.58 B | 15.93% |
2006 | $8.26 B | 20.79% |
2005 | $6.84 B | 17.73% |
2004 | $5.81 B | 10.37% |
2003 | $5.26 B | -1.65% |
2002 | $5.35 B | -10.88% |
2001 | $6.00 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
![]() Amgen AMGN | $26.19 B | 28.01% | ๐บ๐ธ USA |
![]() Baxter BAX | $15.05 B | -26.42% | ๐บ๐ธ USA |
![]() DaVita DVA | $11.66 B | -42.99% | ๐บ๐ธ USA |
![]() IDEXX Laboratories IDXX | $3.43 B | -83.23% | ๐บ๐ธ USA |
![]() Quest Diagnostics
DGX | $9.60 B | -53.06% | ๐บ๐ธ USA |
![]() Teleflex TFX | $2.86 B | -86.02% | ๐บ๐ธ USA |
![]() LabCorp LH | $14.75 B | -27.88% | ๐บ๐ธ USA |
![]() Rockwell Medical
RMTI | $72.81 M | -99.64% | ๐บ๐ธ USA |